{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T16:30:07Z","timestamp":1792773007556,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800301"],"award-info":[{"award-number":["2022YFD1800301"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFD1800300"],"award-info":[{"award-number":["2022YFD1800300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ijbiomac.2026.154132","type":"journal-article","created":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T14:42:38Z","timestamp":1787409758000},"page":"154132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phage-displayed nanobody-peptide conjugates enhance antiviral activity against PRRSV-2 strains"],"prefix":"10.1016","volume":"380","author":[{"given":"Bicheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldryan Cristianto","family":"Pratama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuyang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fushan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154132_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.317.5841.1017","article-title":"Virology. China, Vietnam grapple with 'rapidly evolving' pig virus","volume":"317","author":"Normile","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1006\/viro.1993.1008","article-title":"Lelystad virus, the causative agent of porcine epidemic abortion and respiratory syndrome (pears), is related to ldv and eav","volume":"192","author":"Meulenberg","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.01635","article-title":"Improved vaccine against PRRSV: current progress and future perspective","volume":"8","author":"Nan","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0020","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.virs.2023.08.010","article-title":"Genomic similarity and antibody-dependent enhancement of immune serum potentially affect the protective efficacy of commercial mlv vaccines against NADC30-like PRRSV","volume":"38","author":"Li","year":"2023","journal-title":"Virol. Sin."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00636-25","article-title":"Nsp2 replicase-mediated viral uncoating in porcine alveolar macrophages contributes to the attenuation of PRRSV-2 live attenuated vaccine","author":"Bai","year":"2025","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2015.07.003","article-title":"Innate and adaptive immunity against porcine reproductive and respiratory syndrome virus","volume":"167","author":"Loving","year":"2015","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0035","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.tim.2017.06.001","article-title":"Antiviral strategies against PRRSV infection","volume":"25","author":"Du","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/v15010036","article-title":"Proteomic characterization of pams with PRRSV-ADE infection","volume":"15","author":"Xu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0045","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12951-024-02662-7","article-title":"Nanobody peptide conjugate: a novel CD163 based broad neutralizing strategy against porcine reproductive and respiratory syndrome virus","volume":"22","author":"Yang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110262","article-title":"Role of CD163 in PRRSV infection","volume":"600","author":"Rowland","year":"2024","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2020.105645","article-title":"Recombinant expression of nanobodies and nanobody-derived immunoreagents","volume":"172","author":"de Marco","year":"2020","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fddsv.2022.927164","article-title":"Nanobodies: COVID-19 and future perspectives","volume":"2","author":"Valenzuela-Nieto","year":"2022","journal-title":"Frontiers in Drug Discovery"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0065","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0070","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.drudis.2013.09.001","article-title":"Phage display as a technology delivering on the promise of peptide drug discovery","volume":"18","author":"Hamzeh-Mivehroud","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12929-016-0285-9","article-title":"Phage display as a promising approach for vaccine development","volume":"23","author":"Aghebati-Maleki","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0080","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.3390\/molecules16053499","article-title":"Phage display of combinatorial peptide libraries: application to antiviral research","volume":"16","author":"Castel","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0085","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/cr960065d","article-title":"Phage display","volume":"97","author":"Smith","year":"1997","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab052","article-title":"Phage display and other peptide display technologies","volume":"46","author":"Jaroszewicz","year":"2022","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75205-3","article-title":"Improvements in the production of purified M13 bacteriophage bio-nanoparticle","volume":"10","author":"Passaretti","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10142","article-title":"Phage display as a tool for vaccine and immunotherapy development","volume":"5","author":"Hess","year":"2020","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0105","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2958.2012.08079.x","article-title":"Structural and energetic basis of infection by the filamentous bacteriophage ike","volume":"84","author":"Jakob","year":"2012","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0110","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1007\/s00253-017-8429-8","article-title":"Phage-host associations in a full-scale activated sludge plant during sludge bulking","volume":"101","author":"Liu","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-72077-7_1","article-title":"Filamentous phage: Structure and biology","volume":"1053","author":"Rakonjac","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0120","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1038\/s41598-019-39059-8","article-title":"Emergence of two different recombinant PRRSV strains with low neutralizing antibody susceptibility in China","volume":"9","author":"Han","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0125","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s11262-017-1445-z","article-title":"Characterization and complete genome sequence analysis of a novel virulent siphoviridae phage against staphylococcus aureus isolated from bovine mastitis in xinjiang, China","volume":"53","author":"Zhang","year":"2017","journal-title":"Virus Genes"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0130","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1128\/AAC.00567-12","article-title":"Development of anti-infectives using phage display: Biological agents against bacteria, viruses, and parasites","volume":"56","author":"Huang","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0135","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/348552a0","article-title":"Phage antibodies: Filamentous phage displaying antibody variable domains","volume":"348","author":"McCafferty","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetimm.2003.12.009","article-title":"Recombinant bacteriophage-based multiepitope vaccine against taenia solium pig cysticercosis","volume":"99","author":"Manoutcharian","year":"2004","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0145","article-title":"Isolation and characterization of methicillin-resistant Staphylococcus aureus phage SPB against MRSA planktonic cells and biofilm","volume":"16","author":"Ma","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0150","article-title":"Aptc-c-sa01: A novel bacteriophage cocktail targeting staphylococcus aureus and mrsa biofilms","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0155","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1093\/nar\/gkp809","article-title":"A comprehensive analysis of filamentous phage display vectors for cytoplasmic proteins: an analysis with different fluorescent proteins","volume":"38","author":"Velappan","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0160","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1007\/s00216-023-04606-w","article-title":"M13 phage: A versatile building block for a highly specific analysis platform","volume":"415","author":"Wang","year":"2023","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0165","doi-asserted-by":"crossref","first-page":"21576","DOI":"10.1021\/jacs.2c08529","article-title":"Multivalent pattern recognition through control of nano-spacing in low-valency super-selective materials","volume":"144","author":"Bila","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2020.11.010","article-title":"A quantitative view on multivalent nanomedicine targeting","volume":"169","author":"Woythe","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202114167","article-title":"Significance of receptor mobility in multivalent binding on lipid membranes","volume":"61","author":"Morzy","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0180","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40580-021-00288-1","article-title":"Quantifying and controlling bond multivalency for advanced nanoparticle targeting to cells","volume":"8","author":"Makhani","year":"2021","journal-title":"Nano Converg"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1359-0278(98)00044-3","article-title":"Proteolytic selection for protein folding using filamentous bacteriophages","volume":"3","author":"Kristensen","year":"1998","journal-title":"Fold. Des."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ymeth.2012.12.009","article-title":"Generating thermal stable variants of protein domains through phage display","volume":"60","author":"Pershad","year":"2013","journal-title":"Methods"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12985-019-1199-4","article-title":"Antiviral activity of piscidin 1 against pseudorabies virus both in vitro and in vivo","volume":"16","author":"Hu","year":"2019","journal-title":"Virol. J."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0200","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7841219","article-title":"Caerin 1 peptides, the potential jack-of-all-trades for the multiple antibiotic-resistant bacterial infection treatment and cancer immunotherapy","volume":"2022","author":"Xiao","year":"2022","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/cpch.39","article-title":"Generating fn3-based affinity reagents through phage display","volume":"10","author":"Gorman","year":"2018","journal-title":"Curr. Protoc. Chem. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006206","article-title":"Precision engineering for PRRSV resistance in pigs: macrophages from genome edited pigs lacking CD163 srcr5 domain are fully resistant to both PRRSV genotypes while maintaining biological function","volume":"13","author":"Burkard","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00054-23","article-title":"Identification of new compounds against PRRSV infection by directly targeting CD163","volume":"97","author":"Zhu","year":"2023","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ijbiomac.2022.03.040","article-title":"Broad antiviral peptides against PRRSV based on novel linear epitopes on porcine CD163","volume":"207","author":"Han","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-1135(96)01347-8","article-title":"Virus quantification and identification of cellular targets in the lungs and lymphoid tissues of pigs at different time intervals after inoculation with porcine reproductive and respiratory syndrome virus (PRRSV)","volume":"56","author":"Duan","year":"1997","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198885","article-title":"Prrs virus receptors and an alternative pathway for viral invasion","volume":"320","author":"Ye","year":"2022","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0235","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00709-20","article-title":"Porcine reproductive and respiratory syndrome virus utilizes viral apoptotic mimicry as an alternative pathway to infect host cells","volume":"94","author":"Wei","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.coviro.2021.12.009","article-title":"Endocytosis of bacteriophages","volume":"52","author":"Miernikiewicz","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0245","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2019.01.003","article-title":"Bacteriophage interactions with mammalian tissue: therapeutic applications","volume":"145","author":"Huh","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0250","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01580-21","article-title":"Development of a nanobody-based competitive enzyme-linked immunosorbent assay for efficiently and specifically detecting antibodies against genotype 2 porcine reproductive and respiratory syndrome viruses","volume":"59","author":"Duan","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0255","article-title":"Novel lentivirus-based method for rapid selection of inhibitory nanobody against PRRSV","volume":"12","author":"Liu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10060236","article-title":"Basics of antibody phage display technology","volume":"10","author":"Ledsgaard","year":"2018","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0265","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/17460441.2024.2367023","article-title":"Phage display technology and its impact in the discovery of novel protein-based drugs","volume":"19","author":"Hutchings","year":"2024","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0270","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2213793","article-title":"Evolution of phage display libraries for therapeutic antibody discovery","volume":"15","author":"Zhang","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0275","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847427","article-title":"Filamentous phages: Masters of a microbial sharing economy","volume":"20","author":"Hay","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0280","article-title":"Engineered M13 phage as a novel therapeutic bionanomaterial for clinical applications: from tissue regeneration to cancer therapy","volume":"20","author":"Chang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091936","article-title":"Enhancing the stability of bacteriophages using physical, chemical, and nano-based approaches: A review","volume":"14","author":"Wdowiak","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0290","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tca.2018.12.010","article-title":"Environmental adjustments of the cooperativity in M13 phage thermal denaturation","volume":"672","author":"Gonz\u00e1lez-Cansino","year":"2019","journal-title":"Thermochim. Acta"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0295","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1021\/acs.biochem.0c00205","article-title":"The relationship between effective molarity and affinity governs rate enhancements in tethered kinase-substrate reactions","volume":"59","author":"Speltz","year":"2020","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0300","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.cels.2019.09.007","article-title":"Harnessing avidity: Quantifying the entropic and energetic effects of linker length and rigidity for multivalent binding of antibodies to HIV-1","volume":"9","author":"Einav","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0305","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbrc.2010.09.094","article-title":"Immunological basis of M13 phage vaccine: Regulation under myd88 and tlr9 signaling","volume":"402","author":"Hashiguchi","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0310","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00618-24","article-title":"Filamentous bacteriophage M13 induces proinflammatory responses in intestinal epithelial cells","volume":"93","author":"Varadan","year":"2025","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0315","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jimmun\/vkaf283.308","article-title":"Therapeutic potential of bacteriophage M13 in reducing sepsis-induced inflammation and organ damage in a clp model","volume":"214","author":"Rahimi","year":"2025","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0320","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba1590","article-title":"Bioinorganic hybrid bacteriophage for modulation of intestinal microbiota to remodel tumor-immune microenvironment against colorectal cancer","volume":"6","author":"Dong","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0325","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1080\/17425247.2023.2231345","article-title":"Oral administration of M13-loaded nanoliposomes is safe and effective to treat colitis-associated cancer in mice","volume":"20","author":"Long","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0330","article-title":"Interactions between bacteriophage, bacteria, and the mammalian immune system","volume":"11","author":"Van Belleghem","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11040833","article-title":"A recombinant rbd-based phage vaccine report: a solution to the prevention of new diseases?","volume":"11","author":"Salehi","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/v16020232","article-title":"An engineered M13 filamentous nanoparticle as an antigen carrier for a malignant melanoma immunotherapeutic strategy","volume":"16","author":"Bri\u0161ar","year":"2024","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2026.154132_bb0345","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1751-7915.2008.00028.x","article-title":"Pegylation of bacteriophages increases blood circulation time and reduces t-helper type 1 immune response","volume":"1","author":"Kim","year":"2008","journal-title":"Microb. Biotechnol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302604078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302604078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:06:24Z","timestamp":1792764384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302604078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":69,"alternative-id":["S014181302604078X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154132","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage-displayed nanobody-peptide conjugates enhance antiviral activity against PRRSV-2 strains","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154132"}}